|
The gore® excluder® aaa endoprosthesis instructions for use (ifu) states that adverse events that may occur and/or require intervention include but are not limited to endoleak.Patient weight, comorbidities, and medications will not be released by the hospital and is not available w.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may have not been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
The field sales associate (fsa) reported the following: on (b)(6) 2024, the patient was implanted with gore® excluder® conformable aaa endoprosthesis and gore® excluder® aaa endoprostheses to treat a ruptured abdominal aortic aneurysm.The patient tolerated the procedure.It was reported that the patient was admitted emergently with a ruptured abdominal aortic aneurysm.The patient was hemodynamically unstable through the procedure, several units of blood were given.On (b)(6) 2024, approximately seven hours post endovascular procedure, the physician reintervened to treat a distal type i endoleak in the left common iliac artery.The endoleak was resolved.Reportedly on (b)(6)2024, the patient expired.The physician reported the patient never recovered from being hemodynamically unstable due to the ruptured abdominal aortic aneurysm.There is no allegation that the death or gore device or procedure contributed to or caused the patient¿s death.No further information is available.
|